You are here: Home » News-CM » Companies » Results
Business Standard

Glaxosmithkline Pharmaceuticals consolidated net profit rises 35.04% in the June 2019 quarter

Capital Market 

Sales rise 7.11% to Rs 787.97 crore

Net profit of Glaxosmithkline Pharmaceuticals rose 35.04% to Rs 113.54 crore in the quarter ended June 2019 as against Rs 84.08 crore during the previous quarter ended June 2018. Sales rose 7.11% to Rs 787.97 crore in the quarter ended June 2019 as against Rs 735.65 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales787.97735.65 7 OPM %20.9818.44 -PBDT195.17153.44 27 PBT176.11142.08 24 NP113.5484.08 35

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, July 22 2019. 16:52 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU